XOMA Announces Commencement of Rights Offering
EMERYVILLE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has […]
Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule and Intention to Initiate Patient Studies in Multiple Indications in Collaboration With Sanofi
Phase 1 healthy volunteer study of DNL747 meets all endpoints, including CSF exposure levels, RIPK1 inhibition, and pathway engagement, at […]
Progenics Pharmaceuticals Announces Presentation of Updated Safety and Tolerability Data for AZEDRA® (iobenguane I 131) at the Radiological Society of North America (RSNA) Annual Meeting
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), an oncology company developing innovative medicines and […]
Prudential Bancorp, Inc. Announces Declaration of Dividend and Adoption of New Stock Repurchase Program
PHILADELPHIA, Nov. 19, 2018 (GLOBE NEWSWIRE) — Prudential Bancorp, Inc. (the “Company”) (Nasdaq: PBIP) announced that its Board of Directors, […]
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus
GAITHERSBURG, Md. and SAINT-HERBLAIN, France, Nov. 19, 2018 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) and Valneva SE (VLA) […]
Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference
CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on […]
Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Portuguese Hemp Company
VANCOUVER, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company“) […]
H&R Block to Release Fiscal Second Quarter Results December 5, 2018
KANSAS CITY, Mo., Nov. 19, 2018 (GLOBE NEWSWIRE) — H&R Block, Inc. (NYSE: HRB) will report fiscal 2019 second quarter […]
Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
RUTHERFORD, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for […]
QCR Holdings, Inc. Announces CEO Retirement and Transition
MOLINE, Ill., Nov. 19, 2018 (GLOBE NEWSWIRE) — QCR Holdings, Inc. (NASDAQ: QCRH) (“QCR Holdings” or the “Company”), today announced […]
